Evidence map›Paper›PMID 25521740›Full record

ReviewJournal of gastroenterology and hepatology2014

Prostaglandin pathways in duodenal chemosensing.

Yasutada Akiba, Jonathan D Kaunitz

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of gastroenterology and hepatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Role of pHFrontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yasutada AkibaVeterans Affairs Greater Los Angeles Healthcare System, University of California Los Angeles, Los Angeles, California, USA; Department of Medicine, School of Medicine, University of California Los Angeles, Los Angeles, California, USA; Brentwood Biomedical Research Institute, Los Angeles, California, USA.
Jonathan D Kaunitz
University of California, Los Angeles · US

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
Duodenal Muscosal Defense MechanismsR01DK054221 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KAUNITZ, JONATHAN D. · 1999 to 2016
$4.4M
Luminal Factors Affecting Duodenal Protection and ChemosensingI01BX001245 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI KAUNITZ, JONATHAN D. · 2012 to 2025
–
BLRD VA I01 BX001245NIDDK NIH HHS P30 DK041301NIDDK NIH HHS R01 DK054221NIDDK NIH HHS R01 DK54221
6 · The paper itself

Abstract

Acid-sensing pathways, which trigger mucosal defense mechanisms in response to luminal acid, involve the rapid afferent-mediated "capsaicin pathway" and the sustained "prostaglandin (PG) pathway." Luminal acid quickly increases protective PG synthesis and release from epithelia, although the mechanism by which luminal acid induces PG synthesis is still mostly unknown. Acid exposure augments purinergic ATP-P2Y signaling by inhibition of intestinal alkaline phosphatase activity. Since P2Y activation increases intracellular Ca2+, we further hypothesized that ATP-P2Y signals increase the generation of H2O2 derived from dual oxidase, a member of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase family activated by Ca2+. Our recent studies suggest that acid exposure increases H2O2 output, followed by phospholipase A2 and cyclooxygenase activation, increasing PG synthesis. Released prostaglandin E2 augments protective HCO3- and mucus secretion via EP4 receptor activation. Thus, the PG pathway as a component of duodenal acid sensing consists of acid-related intestinal alkaline phosphatase inhibition, ATP-P2Y signals, dual oxidase 2-derived H2O2 production, phospholipase A2 activation, prostaglandin E2 synthesis, and EP4 receptor activation. The PG pathway is also involved in luminal bacterial sensing in the duodenum via activation of pattern recognition receptors, including Toll-like receptors and nucleotide-binding oligomerization domain 2. The presence of acute mucosal responses to luminal bacteria suggests that the duodenum is important for host defenses and may reduce bacterial loading to the hindgut using H2O2, complementing gastric acidity and anti-bacterial bile acids.

Indexed as

Adenosine TriphosphateBacterial AdhesionBicarbonatesCalciumDinoprostoneDuodenumGastric AcidHumansHydrogen-Ion ConcentrationHydrogen PeroxideIntestinal MucosaNADPH OxidasesPhospholipases A2Prostaglandin-Endoperoxide SynthasesReceptors, Pattern RecognitionReceptors, Prostaglandin E, EP4 SubtypeAdenosine TriphosphateBicarbonatesCalciumDinoprostoneHydrogen PeroxideNADPH OxidasesPhospholipases A2Prostaglandin-Endoperoxide SynthasesReceptors, Pattern RecognitionReceptors, Prostaglandin E, EP4 SubtypeReceptors, Purinergic P2Yacid sensingATP-P2Y signalbacterial sensingdual oxidase

Identifiers

PMID25521740
PMCPMC4451058
OpenAlexW1851715401

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.